A psychiatric nurse practitioner shares tips for therapy, part 2

How I manage fatigue and sleep while living with Huntington’s

Fatigue and sleep disruptions have been some of the most challenging aspects for me while living with Huntington’s disease. They creep in slowly, often unnoticed at first, until they begin to shape the rhythm of my daily life. Managing them has required a combination of self-awareness, adaptability, and a…

Wave planning potentially pivotal trial of WVE-003 in patients

Wave Life Sciences is making plans to launch a potentially pivotal Phase 2/3 clinical trial in the U.S. to test its therapy candidate WVE-003 in people with Huntington’s disease. Pivotal trials are those whose data, if positive, are meant to be used to support applications seeking a treatment’s…

Celebrating St. Patrick’s Day on my own terms

Every year, as March 17 approaches, the world turns a vibrant shade of green. People gather in pubs, clink glasses in celebration, and revel in the joy of St. Patrick’s Day. It’s a holiday known for its infectious energy, lively music, and, of course, flowing drinks. But for me, the…

How I embrace spring cleaning for the mind, body, and soul

As the snow melts and the first flowers bloom, I welcome spring as a season of renewal. For me, spring cleaning isn’t just about scrubbing floors and reorganizing closets; it’s about decluttering my mind, refreshing my body, and realigning my spirit. Living with Huntington’s disease means that every season…

LETI-101 lowers mutant HTT protein in preclinical models

LETI-101, an experimental gene-editing therapy for Huntington’s disease, showed promising proof-of-concept effects in mouse and cell models by reducing levels of the disease-causing mutant huntingtin (HTT) protein, while preserving HTT’s healthy version. In nonhuman primates, the therapy showed good safety and distribution across brain regions profoundly impacted by Huntington’s. The…